Nová léčiva v terapii ovariálního karcinomu aneb proč zůstává základem primární radikální výkon
| Title in English | New drugs in therapy of ovarian cancer, or why radical surgery remains the primary therapeutic method |
|---|---|
| Authors | |
| Year of publication | 2016 |
| Type | Article in Periodical |
| Magazine / Source | Postgraduální medicína |
| Citation | |
| Field | Oncology and hematology |
| Keywords | ovarian cancer-surgery - antiangiogenics therapy |
| Description | The continuing high mortality of ovarian cancer represents a challenge for researching more efficient ways of treating this disease. New therapeutic methods, especially targeted biological treatment, bring encouraging results. Even so, surgery and chemotherapy remain the primary modes of treatment |